Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2007-10-25
2010-11-16
Romeo, David S (Department: 1647)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S023400, C435S252300, C435S325000, C435S320100
Reexamination Certificate
active
07834164
ABSTRACT:
Disclosed is a composition of matter comprising an OSK1 peptide analog, and in some embodiments, a pharmaceutically acceptable salt thereof. A pharmaceutical composition comprises the composition and a pharmaceutically acceptable carrier. Also disclosed are DNAs encoding the inventive composition of matter, an expression vector comprising the DNA, and host cells comprising the expression vector. Methods of treating an autoimmune disorder and of preventing or mitigating a relapse of a symptom of multiple sclerosis are also disclosed.
REFERENCES:
patent: 3691016 (1972-09-01), Patel
patent: 3941763 (1976-03-01), Sarantakis
patent: 3969287 (1976-07-01), Jaworek et al.
patent: 4083368 (1978-04-01), Freezer
patent: 4195128 (1980-03-01), Hildebrand et al.
patent: 4229537 (1980-10-01), Hodgins et al.
patent: 4247642 (1981-01-01), Hirohara et al.
patent: 4330440 (1982-05-01), Ayers et al.
patent: 4351337 (1982-09-01), Sidman
patent: 4686283 (1987-08-01), Nestor et al.
patent: 4847325 (1989-07-01), Shadle et al.
patent: 4849224 (1989-07-01), Chang et al.
patent: 4906159 (1990-03-01), Sabo et al.
patent: 4906169 (1990-03-01), Chien et al.
patent: 4911916 (1990-03-01), Cleary
patent: 4925673 (1990-05-01), Steiner et al.
patent: 4925677 (1990-05-01), Feijen
patent: 4983395 (1991-01-01), Chang et al.
patent: 4994439 (1991-02-01), Longenecker et al.
patent: 5013556 (1991-05-01), Woodle et al.
patent: 5023084 (1991-06-01), Chien et al.
patent: 5166322 (1992-11-01), Shaw et al.
patent: 5171264 (1992-12-01), Merrill
patent: 5206344 (1993-04-01), Katre et al.
patent: 5252714 (1993-10-01), Harris et al.
patent: 5284656 (1994-02-01), Platz et al.
patent: 5302697 (1994-04-01), Goodey et al.
patent: 5346701 (1994-09-01), Heiber et al.
patent: 5397702 (1995-03-01), Cahalan et al.
patent: 5446090 (1995-08-01), Harris
patent: 5460820 (1995-10-01), Ebert et al.
patent: 5484895 (1996-01-01), Meister et al.
patent: 5494895 (1996-02-01), Garcia et al.
patent: 5516523 (1996-05-01), Heiber et al.
patent: 5605702 (1997-02-01), Teillaud et al.
patent: 5643575 (1997-07-01), Martinez et al.
patent: 5662925 (1997-09-01), Ebert et al.
patent: 5672688 (1997-09-01), Kobayashi et al.
patent: 5714142 (1998-02-01), Blaney et al.
patent: 5739208 (1998-04-01), Harris
patent: 5739277 (1998-04-01), Presta et al.
patent: 5763478 (1998-06-01), Baker et al.
patent: 5783208 (1998-07-01), Venkateshwaran et al.
patent: 5792451 (1998-08-01), Sarubbi et al.
patent: 5827655 (1998-10-01), Chandy et al.
patent: 5900461 (1999-05-01), Harris
patent: 5919455 (1999-07-01), Greenwald et al.
patent: 5932462 (1999-08-01), Harris et al.
patent: 5990237 (1999-11-01), Bentley et al.
patent: 6022952 (2000-02-01), Weiner et al.
patent: 6077680 (2000-06-01), Kem et al.
patent: 6096891 (2000-08-01), Carr et al.
patent: 6245740 (2001-06-01), Goldenberg et al.
patent: 6267964 (2001-07-01), Nygren et al.
patent: 6273086 (2001-08-01), Ohki et al.
patent: 6335178 (2002-01-01), Weiner et al.
patent: 6342225 (2002-01-01), Jones et al.
patent: 6451986 (2002-09-01), Pettit
patent: 6548644 (2003-04-01), Pettit
patent: 6551821 (2003-04-01), Kandel et al.
patent: 6552170 (2003-04-01), Thompson et al.
patent: 6602498 (2003-08-01), Shen
patent: 6610281 (2003-08-01), Harris
patent: 6632928 (2003-10-01), Neville et al.
patent: 6660843 (2003-12-01), Feige et al.
patent: 6689749 (2004-02-01), Lebrun et al.
patent: 6703485 (2004-03-01), Kandel et al.
patent: 6740743 (2004-05-01), Herrmann et al.
patent: 6768002 (2004-07-01), Herrmann et al.
patent: 6774106 (2004-08-01), Theill et al.
patent: 6818418 (2004-11-01), Lipovsek et al.
patent: 6849714 (2005-02-01), Bridon et al.
patent: 6861405 (2005-03-01), Desir et al.
patent: 6887470 (2005-05-01), Bridon et al.
patent: 6892728 (2005-05-01), Helgesson et al.
patent: 6894025 (2005-05-01), Harris
patent: 6900317 (2005-05-01), Trunk et al.
patent: 6905688 (2005-06-01), Rosen et al.
patent: 6926898 (2005-08-01), Rosen et al.
patent: 6932962 (2005-08-01), Bäckström et al.
patent: 6946134 (2005-09-01), Rosen et al.
patent: 6989365 (2006-01-01), Fleer et al.
patent: 7005436 (2006-02-01), Lloyd et al.
patent: 7029909 (2006-04-01), Uemura et al.
patent: 7096942 (2006-08-01), de Rouffignac et al.
patent: 7288254 (2007-10-01), Neville et al.
patent: 7348004 (2008-03-01), Peters et al.
patent: 7381408 (2008-06-01), Mezo et al.
patent: 7404956 (2008-07-01), Peters et al.
patent: 2003/0069170 (2003-04-01), Soltero et al.
patent: 2003/0069395 (2003-04-01), Sato et al.
patent: 2003/0104400 (2003-06-01), Ruben et al.
patent: 2003/0191056 (2003-10-01), Walker et al.
patent: 2003/0195154 (2003-10-01), Walker et al.
patent: 2004/0039167 (2004-02-01), Sabatier et al.
patent: 2004/0044188 (2004-03-01), Feige et al.
patent: 2004/0121959 (2004-06-01), Boone et al.
patent: 2005/0054051 (2005-03-01), Rosen et al.
patent: 2005/0054570 (2005-03-01), Rosen et al.
patent: 2007/0071764 (2007-03-01), Sullivan et al.
patent: 2007/0105199 (2007-05-01), Yan et al.
patent: 0 219 716 (1987-04-01), None
patent: 0 315 456 (1994-06-01), None
patent: 0 668 353 (1995-08-01), None
patent: 0 668 354 (1995-08-01), None
patent: 0 473 084 (1995-11-01), None
patent: 0 469 074 (1996-07-01), None
patent: 0 575 545 (2003-05-01), None
patent: WO 88/06451 (1988-09-01), None
patent: WO 92/02634 (1992-02-01), None
patent: WO 95/03065 (1995-02-01), None
patent: WO 95/13312 (1995-05-01), None
patent: WO 96/05309 (1996-02-01), None
patent: WO 96/05309 (1996-02-01), None
patent: WO 96/11953 (1996-04-01), None
patent: WO 96/32478 (1996-10-01), None
patent: WO 97/34631 (1997-09-01), None
patent: WO 98/23639 (1998-06-01), None
patent: WO 98/39363 (1998-09-01), None
patent: WO 99/24055 (1999-05-01), None
patent: WO 99/38008 (1999-07-01), None
patent: WO 00/38651 (2000-07-01), None
patent: WO 00/38652 (2000-07-01), None
patent: WO 00/69900 (2000-11-01), None
patent: WO 01/83525 (2001-11-01), None
patent: WO 02/11801 (2002-02-01), None
patent: WO 02/098446 (2002-12-01), None
patent: WO 02/100248 (2002-12-01), None
patent: WO 2004/017918 (2004-03-01), None
patent: WO 2004/026329 (2004-04-01), None
patent: WO 2004/043396 (2004-05-01), None
patent: WO 2004/110472 (2004-12-01), None
patent: WO 2005/047337 (2005-05-01), None
patent: WO 2006/002850 (2006-01-01), None
patent: WO 2006/036834 (2006-04-01), None
patent: WO 2006/042151 (2006-04-01), None
patent: WO 2006/116156 (2006-11-01), None
patent: WO 2007/022070 (2007-02-01), None
patent: 2007048037 (2007-04-01), None
patent: WO 2007/045463 (2007-04-01), None
Bowie et al. Deciphering the message in protein sequences: tolerance to amino acid substitutions. Science, (Mar.16, 1990) 247 (4948) 1306-10.
Ngo et al., in The Protein Folding Problem and Tertiary Structure Prediction, Merz and Le Grand (Eds), Aug. 1994, Springer Verlag, pp. 433 and 492-495.
Abdul, et al., “Activity of Potassium Channel-blockers in Breast Cancer”,Anticancer Research, 23: 3347-3352 (2003).
Abuchowski, et al., “Soluble Polymer-Enzyme Adducts”,Enzymes as Drugs, pp. 362-383 (1981).
Adams, et al., “Conotoxins and their Potential Pharmaceutical Applications”,Drug Devel. Research, 46: 219-234 (1999).
Adjei, et al., Pulmonary Delivery of Peptide Drugs: Effect of Particle Size on Bioavailability of Leuprolide Acetate in Healthy Male Volunteers,Pharma. Res., 7: 565-569 (1990).
Adjei, et al., “Bioavailability of Leuprolide Following Intratracheal Administration to Beagle Dogs”,Internatl. J Pharmaceutics, 61: 135-144 (1990).
“Advanced Chemtech Handbook of Combinatorial and Solid Phase Organic Chemistry”, Bennett, W.D. (ed.), Advanced Chem Tech, Inc., Louisville, Kentucky, (1998) (Provided Table of Contents only).
Alberts, et al., “Synthesis of a Novel Hematopoietic Peptide SK&F 107647”,Thirteenth Am. Pep. Symp., pp. 367-369 (1993).
Altschul, et al, “Gapped BLAST and PSI-BLAST: A New Generation of Protein Database Search Programs”,Nuc. Acids Res., 25: 3389-3402 (1997).
Azam, et al., “Targeting Effector Memory T Cells with the Small Molecule Kv1.3 Blocker PAP-1
Gegg, Jr. Colin V.
Hu Shaw-Fen Sylvia
McGivern Joseph G.
Miranda Leslie P.
Nguyen Hung Q.
Amgen Inc.
Romeo David S
Steinberg Nisan A.
LandOfFree
DNA encoding OSK1 toxin peptide analogs and vectors and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with DNA encoding OSK1 toxin peptide analogs and vectors and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA encoding OSK1 toxin peptide analogs and vectors and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4186831